Inari Medical Inc (NASDAQ: NARI) closed the day trading at $39.49 down -3.16% from the previous closing price of $40.78. On the day, 1229611 shares were traded.
Ratios:
For a better understanding of NARI, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.72 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 73.31. For the most recent quarter (mrq), Quick Ratio is recorded 2.52 and its Current Ratio is at 3.09. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on February 29, 2024, Downgraded its rating to Neutral and sets its target price to $55 from $85 previously.
On January 23, 2024, Needham started tracking the stock assigning a Buy rating and target price of $72.
On July 19, 2023, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $79.Robert W. Baird initiated its Outperform rating on July 19, 2023, with a $79 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 18 ’24 when Hoffman William sold 40,000 shares for $41.13 per share. The transaction valued at 1,645,079 led to the insider holds 1,003,296 shares of the business.
Hill, Mitch C. sold 6,000 shares of NARI for $251,461 on Mar 12 ’24. The Chief Financial Officer now owns 183,361 shares after completing the transaction at $41.91 per share. On Dec 15 ’23, another insider, Hoffman William, who serves as the Director of the company, sold 25,000 shares for $65.08 each. As a result, the insider received 1,627,073 and left with 1,045,493 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.64 while its Price-to-Book (P/B) ratio in mrq is 4.91.
Stock Price History:
Over the past 52 weeks, NARI has reached a high of $71.85, while it has fallen to a 52-week low of $39.90.
Shares Statistics:
A total of 57.76M shares are outstanding, with a floating share count of 49.58M. Insiders hold about 14.45% of the company’s shares, while institutions hold 88.07% stake in the company.
Earnings Estimates
Current recommendations for the stock of the company come from Apollo Commercial Real Estate F analysts. The consensus estimate for the next quarter is $39.49, with high estimates of $8.09 and low estimates of $16.15.
Analysts are recommending an EPS of between $Industrials and $Financial Services for the fiscal current year, implying an average EPS of $Healthcare.
